UTHR- United Therapeutics Corporation

Name: United Therapeutics Corporation Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

United Therapeutics Corporation (UTHR) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 95 sells. UTHR is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Rothblatt Martine A	324.9K	$168.62M	-76,000
VP	Mahon Paul A	40.2K	$20.86M	-
CFO	Edgemond James	18.9K	$9.80M	-
Dir	Kurzweil Ray	17.6K	$9.12M	-
CFO	Edgemond James	11.7K	$6.05M	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 20, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$577.83	$5,489,423.82	-1.5%	-7.7%	-
Mar 16, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$537.81	$5,109,148.28	-16.5%	+2.2%	-
Mar 11, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$539.54	$5,125,646.80	-14.7%	+1.5%	-
Mar 10, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$539.71	$5,127,273.03	-10.7%	+2.6%	-
Mar 5, 2026	Mahon Paul A46	EVP &General Counsel	Sale+OE	8,300	$483.16	$4,010,187.14	-2.2%	+12.9%	-
Mar 4, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	19,000	$317.97	$6,041,413.58	-30.9%	+11.1%	-
Mar 4, 2026	Kurzweil Ray	Director	Sale+OE	4,910	$489.02	$2,401,088.20	-27.9%	+11.1%	-
Mar 4, 2026	Thompson Tommy G51	Director	Sale+OE	2,000	$489.42	$978,839.40	-19.1%	+11.1%	-
Mar 4, 2026	Causey Christopher59	Director	Sale+OE	20	$490.17	$9,803.37	-0.5%	+11.1%	-
Mar 3, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$499.42	$4,744,466.67	-11.5%	+11.7%	-

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC